228 related articles for article (PubMed ID: 31607620)
1. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
[TBL] [Abstract][Full Text] [Related]
3. A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.
Herden U; Sterneck M; Buchholz BM; Achilles EG; Ott A; Fischer L
Immun Inflamm Dis; 2021 Dec; 9(4):1771-1780. PubMed ID: 34559956
[TBL] [Abstract][Full Text] [Related]
4. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
5. Conversion From a Twice-Daily to a Once-Daily Tacrolimus Formulation in Kidney Transplant Recipients.
Kamińska D; Poznański P; Kuriata-Kordek M; Zielińska D; Mazanowska O; Kościelska-Kasprzak K; Krajewska M
Transplant Proc; 2020 Oct; 52(8):2288-2293. PubMed ID: 32247597
[TBL] [Abstract][Full Text] [Related]
6. Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.
Grinyó JM; Petruzzelli S
Expert Rev Clin Immunol; 2014 Dec; 10(12):1567-79. PubMed ID: 25407098
[TBL] [Abstract][Full Text] [Related]
7. Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Fontova P; Colom H; Rigo-Bonnin R; Bestard O; Vidal-Alabró A; van Merendonk LN; Cerezo G; Polo C; Montero N; Melilli E; Manonelles A; Meneghini M; Coloma A; Cruzado JM; Torras J; Grinyó JM; Lloberas N
Clin Pharmacol Ther; 2021 Jul; 110(1):238-247. PubMed ID: 33626199
[TBL] [Abstract][Full Text] [Related]
8. Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.
Marubashi S; Wada H; Kobayashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Hepatogastroenterology; 2012 Jun; 59(116):1184-8. PubMed ID: 22172333
[TBL] [Abstract][Full Text] [Related]
9. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
10. Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
Giral M; Grimbert P; Morin B; Bouvier N; Buchler M; Dantal J; Garrigue V; Bertrand D; Kamar N; Malvezzi P; Moreau K; Athea Y; Le Meur Y
Transpl Int; 2024; 37():11571. PubMed ID: 38694490
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
DuBay DA; Teperman L; Ueda K; Silverman A; Chapman W; Alsina AE; Tyler C; Stevens DR
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):995-1008. PubMed ID: 30667591
[TBL] [Abstract][Full Text] [Related]
12. Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients.
Tan T; Bunnapradist S
Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1175-1186. PubMed ID: 34459696
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
Uemoto S; Abe R; Horike H; So M
Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
[TBL] [Abstract][Full Text] [Related]
14. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of the conversion to MeltDose
Sánchez Fructuoso A; Ruiz JC; Franco A; Diekmann F; Redondo D; Calviño J; Serra N; Aladrén MJ; Cigarrán S; Manonelles A; Ramos A; Gómez G; González Posada JM; Andrés A; Beneyto I; Muñiz AL; Perelló M; Lauzurica R
Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients.
Choi D; Thaker S; West-Thielke P; Elmasri A; Chan C
Eur J Gastroenterol Hepatol; 2021 Aug; 33(8):1124-1128. PubMed ID: 34213506
[TBL] [Abstract][Full Text] [Related]
18. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
19. Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in
Budde K; Rostaing L; Maggiore U; Piotti G; Surace D; Geraci S; Procaccianti C; Nicolini G; Witzke O; Kamar N; Albano L; Büchler M; Pascual J; Gutiérrez-Dalmau A; Kuypers D; Wekerle T; Głyda M; Carmellini M; Tisone G; Midtvedt K; Wennberg L; Grinyó JM
Transpl Int; 2022; 35():10225. PubMed ID: 36017158
[No Abstract] [Full Text] [Related]
20. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
Lu Z; Bonate P; Keirns J
Br J Clin Pharmacol; 2019 Aug; 85(8):1692-1703. PubMed ID: 30950096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
